Ahsan Hussain, MD
Retina Specialist · Toms River, NJNPI 1255829982
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 9 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 6 manufacturers reported payments, led by Alcon at 34.2% of the total. Reporting peaked in 2024 at $246 and has fallen 69.6% since, to $75 in 2025. That places this record below the midpoint for retina specialist clinicians in NJ, where the typical reported total is $2,776.
Across 9 payments — averaging $54.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alcon$167
- Apellis Pharmaceuticals, Inc.$122
- AbbVie$107
- Genentech USA, Inc.$61
- Harrow Eye, LLC$17
- Regeneron Healthcare Solutions, Inc.$14
What the payments were for
- Food & beverage$488100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alcon | 1 | $167 |
| Apellis Pharmaceuticals, Inc. | 2 | $122 |
| AbbVie | 1 | $107 |
| Genentech USA, Inc. | 3 | $61 |
| Harrow Eye, LLC | 1 | $17 |
| Regeneron Healthcare Solutions, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Constellation$167
- OZURDEX$107
- Syfovre$106
How this compares
$488 in reported general payments places this provider in the 10th percentile of 35 retina specialist providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 73 | $2,106 |
| MoxifloxacinMoxifloxacin Hcl | 32 | $682 |
| Atropine Sulfate | 15 | $371 |
| Ofloxacin | 19 | $196 |
| Brimonidine Tartrate | 20 | $146 |
Paid to pharmacies, not to this prescriber.
Other retina specialist in Toms River
- Ravi PatelToms River$18K
- Haris AminToms River$1K
- Mohammedyusuf HajeeToms River$1K
- Howard FineNew Brunswick$955K
- Joshua MaliFlemington$230K
- Jonathan PrennerNew Brunswick$215K
- Leonard FeinerUnion$72K
- Daniel RothNew Brunswick$61K
- Sumit ShahNew Brunswick$41K
- Vatsal DoshiMillburn$32K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.